Egalet Corp (EGLT)

7.37
0.58 8.54
NASDAQ : Health Care
Prev Close 6.79
Open 6.90
Day Low/High 6.86 / 7.47
52 Wk Low/High 4.34 / 16.59
Volume 148.26K
Avg Volume 139.30K
Exchange NASDAQ
Shares Outstanding 25.09M
Market Cap 168.07M
EPS -2.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Egalet Announces Issuance Of Two New U.S. Patents For Guardian™ Technology

Egalet Announces Issuance Of Two New U.S. Patents For Guardian™ Technology

--Patents cover extended-release formulations of opioids, and immediate-release formulations intended to resist 'dose dumping' for opioids--

Insider Trading Alert - EGLT, FMI And ICLD Traded By Insiders

Insider Trading Alert - EGLT, FMI And ICLD Traded By Insiders

Stocks with insider trader activity include EGLT, FMI and ICLD

Egalet Enters Oversold Territory (EGLT)

Egalet Enters Oversold Territory (EGLT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Egalet Settles Patent Litigations With Purdue Pharma

Egalet Settles Patent Litigations With Purdue Pharma

--No financial obligations to either party--

Relative Strength Alert For Egalet

Relative Strength Alert For Egalet

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Egalet Announces Scientific Presentations At American Pain Society Meeting

Egalet Announces Scientific Presentations At American Pain Society Meeting

--Data demonstrate ARYMO™ ER has a strong abuse-deterrent profile and does not dose dump in the presence of alcohol --

Egalet Announces Upcoming Opportunities For Community To Dispose Of Prescription Medications

Egalet Announces Upcoming Opportunities For Community To Dispose Of Prescription Medications

-- 2nd Annual Community Day, an educational event and opportunity for people to dispose of unused prescription medications, to take place April 23 in Media, PA --

Insider Trading Alert - CTSH, EGLT And CMC Traded By Insiders

Insider Trading Alert - CTSH, EGLT And CMC Traded By Insiders

Stocks with insider trader activity include CTSH, EGLT and CMC

Insider Trading Alert - PNY, EGLT And MA Traded By Insiders

Insider Trading Alert - PNY, EGLT And MA Traded By Insiders

Stocks with insider trader activity include PNY, EGLT and MA

Insider Trading Alert - ATOS, EGLT And VRNS Traded By Insiders

Insider Trading Alert - ATOS, EGLT And VRNS Traded By Insiders

Stocks with insider trader activity include ATOS, EGLT and VRNS

Egalet Signs Agreement With Septodont, Inc. To Promote SPRIX® (ketorolac Tromethamine) Nasal Spray To Dentists In United States

Egalet Signs Agreement With Septodont, Inc. To Promote SPRIX® (ketorolac Tromethamine) Nasal Spray To Dentists In United States

--Data published in Postgraduate Medicine supports use of SPRIX Nasal Spray as effective non-opioid option post dental procedures--

Oversold Conditions For Egalet (EGLT)

Oversold Conditions For Egalet (EGLT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Insider Trading Alert - ADSK, EGLT And CPE Traded By Insiders

Insider Trading Alert - ADSK, EGLT And CPE Traded By Insiders

Stocks with insider trader activity include ADSK, EGLT and CPE

Insider Trading Alert - PLOW, DST And EGLT Traded By Insiders

Insider Trading Alert - PLOW, DST And EGLT Traded By Insiders

Stocks with insider trader activity include PLOW, DST and EGLT

Egalet Submits New Drug Application To U.S. Food And Drug Administration For ARYMO™ ER (Morphine Sulfate) Extended-Release Tablets

Egalet Submits New Drug Application To U.S. Food And Drug Administration For ARYMO™ ER (Morphine Sulfate) Extended-Release Tablets

--NDA includes comprehensive package of bioequivalence and abuse-deterrent data--